Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
RANI
#3426
Rani Therapeutics Holdings, Inc. Class A Common Stock
1.3
7
-0.72%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
-0.72%
Monthly Change
-0.72%
6 month change
+140.35%
Cambio anual
-8.67%
Cierres anteriores
1.3
8
Open
1.3
7
Bid
Ask
Low
1.3
7
High
1.3
7
Volumen
19
Markets
Acciones
Atención Sanitaria
RANI
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
Dividend yield %
—
—
—
—
—
Payout ratio %
—
—
—
—
—
Noticias
Rani Therapeutics promuove Alireza Javadi a direttore tecnico
Rani Therapeutics promotes Alireza Javadi to chief technical officer
Rani Therapeutics avvia trial di fase 1 per trattamento orale dell’obesità
Rani Therapeutics begins phase 1 trial of oral obesity treatment
Rani Therapeutics modifica lo statuto, riduce il potere di voto delle azioni di Classe B
Rani Therapeutics amends charter, reduces Class B voting power and ends tax agreement
Rani Therapeutics annuncia collaborazione da 1,085 miliardi di dollari con Chugai
Rani Therapeutics announces $1.085 billion Chugai collaboration
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.09%
Monday’s Insider Moves: Top Buys and Sells in US Stocks on October 27
Il direttore di Rani Therapeutics Imran Mir A acquista azioni per 1,26 milioni di dollari
Rani Therapeutics director Imran Mir a buys $1.26 million in stock